Merck Manual

Please confirm that you are a health care professional

Yes No

Leave this Site?

The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.

Continue Cancel
Merck Manual
Professional Version
The trusted provider of medical information since 1899
Medical Topics & Chapters
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Merck Manual
Professional Version
The trusted provider of medical information since 1899
Medical Topics & Chapters
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Professional /
Dental Disorders /
Periodontal Disorders /
... /
Gingival Hyperplasia /

OTHER TOPICS IN THIS CHAPTER

Periodontal Disorders
Overview of Periodontal Disease
Acute Necrotizing Ulcerative Gingivitis (ANUG)
Gingival Hyperplasia
Gingivitis
Peri-Implant Diseases and Conditions

Test your knowledge

Postextraction Problems
Postextraction alveolitis (dry socket) is most likely to occur in patients who have had which of the following teeth removed?

More Content

Loading

Gingival Hyperplasia

By

James T. Ubertalli

, DMD, Hingham, MA

Last full review/revision Jul 2020| Content last modified Jul 2020
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Topic Resources

Hyperplasia of gingival tissues without inflammation may occur in response to various drugs.

Drugs that particularly cause gingival hyperplasia include the following:

  • Phenytoin

  • Cyclosporine

  • Nifedipine and other calcium channel blockers

Hyperplasia is characterized by diffuse, relatively avascular smooth or nodular enlargement of the gingiva, which may almost cover some teeth. The hypertrophied tissue can often be excised. If possible, substitutions are made for the offending drugs. Scrupulous oral hygiene may minimize recurrence.

Oral squamous cell carcinoma can also originate in the gingiva, causing apparent enlargement of gum tissue.

Drugs Mentioned In This Article

Drug Name Select Trade
Cyclosporine
 NEORAL, SANDIMMUNE
Nifedipine
 ADALAT CC, PROCARDIA
Phenytoin
 DILANTIN
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
© 2020 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA)
Acute Necrotizing Ulcerative Gingivitis (ANUG)
Gingivitis
Professionals also read
Gingivitis Gingivitis
Overview of Congenital Adrenal Hyperplasia Overview of Congenital Adrenal Hyperplasia
Systemic Disorders and the Mouth Systemic Disorders and the Mouth

Also of Interest

Videos

View All
How To Do an Inferior Alveolar Nerve Block
Video
How To Do an Inferior Alveolar Nerve Block
3D Models
View All
Tooth: Cross Section
3D Model
Tooth: Cross Section

SOCIAL MEDIA

Merck and the Merck Manuals

Merck & Co., Inc., Kenilworth, NJ, USA is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world.  The Merck Manual was first published in 1899 as a service to the community.  The legacy of this great resource continues as the Merck Manual in the US and Canada and the MSD Manual outside of North America.  Learn more about our commitment to Global Medical Knowledge.

TRUSTe
TRUSTe

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:  
verify here.

© 2020 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
TOP